The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

Although these diseases were initially treated by transplantation of allogeneic hematopoietic stem cells, the past 20 years has shown that these conditions are correctable by gene therapy.

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Eugene Albert "Gene" Jonart, a devoted husband, father, and friend, passed peacefully in his sleep on January 28, 2025, at the age of 83. Born on April 28, 1941, in Butte, Montana, Gene lived a life ...

In October 2024, the activist investor carved out a $1 billion stake in the pharma, noting at the time that it had lost faith in the company’s current leadership, especially CEO Albert Bourla ... such ...

MORE GENETIC MODIFICATIONS: Gene Therapy at Duke Improves NC Dad’s Failing Vision Just in Time for His Baby’s Birth “In my opinion, I’m perfect. I never felt fine before—before ...

Janet Glockler-Hooke told 880 CHED she was headed to a mall in St. Albert, Alta., on Saturday and when she turned into the parking lot, she noticed three men holding signs and flags that concerned ...

Shortly before the Starboard situation came to light, Pfizer in September pulled the centerpiece of the transaction—the sickle cell disease therapy ... Pfizer's CEO, Albert Bourla, Ph.D ...

The company, which secured $200 million from investors in a private funding deal last week, learned Tuesday of a serious side effect experienced by one participant on a high dose of its Rett therapy.

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients ...

Roger Hajjar, ’86, is the inaugural director of the Gene and Cell Therapy Institute at Mass General Brigham and the president, chief medical officer, and co-founder of Medera, a clinical-stage ...